Certified by Founder Lodge
ANTABIO
France - Labege
START UP
1 Disclosed Funding Rounds $26,976,000
0 Participating Investments
-
Founded date
2009
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. Two of Antabio’s p
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 13 ,2023 | Series B | $26,976,000 |
IRDI Capital Investissement
AMR Action Fund
BNP Paribas Développement
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
